BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29300232)

  • 1. Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.
    Cullaro G; Pisa JF; Brown RS; Wagener G; Verna EC
    Transplantation; 2018 May; 102(5):809-815. PubMed ID: 29300232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for Renal Injury in Liver Transplant Recipients Using Calcineurin Inhibitors.
    Yoon KC; Lee KW; Oh SC; Kim H; Kim HS; Hong SK; Ahn SW; Yi NJ; Suh KS
    Transplant Proc; 2018 Dec; 50(10):3667-3672. PubMed ID: 30577253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of urinary neutrophil gelatinase-associated lipoprotein in living kidney donors: toward understanding differences between chronic kidney diseases of surgical and medical origin.
    Yoon YE; Lee HH; Na JC; Han WK
    BJU Int; 2019 May; 123(5):869-876. PubMed ID: 30347133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.
    Sokolski M; Zymliński R; Biegus J; Siwołowski P; Nawrocka-Millward S; Todd J; Yerramilli MR; Estis J; Jankowska EA; Banasiak W; Ponikowski P
    Eur J Heart Fail; 2017 Jun; 19(6):760-767. PubMed ID: 28133864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransplant urinary proteome analysis does not predict development of chronic kidney disease after liver transplantation.
    Milongo D; Bascands JL; Huart A; Esposito L; Breuil B; Moulos P; Siwy J; Ramírez-Torres A; Ribes D; Lavayssière L; Del Bello A; Muscari F; Alric L; Bureau C; Rostaing L; Schanstra JP; Kamar N
    Liver Int; 2015 Jul; 35(7):1893-901. PubMed ID: 25515948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin associated with irreversibility of pre-liver transplant kidney dysfunction.
    Aberg F; Lempinen M; Hollmén M; Nordin A; Mäkisalo H; Isoniemi H
    Clin Transplant; 2014 Aug; 28(8):869-76. PubMed ID: 24930480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.
    Uguen T; Jezequel C; Ropert M; Houssel-Debry P; Latournerie M; Lainé F; Deugnier Y; Vigneau C; Boudjema K; Guyader D; Bardou-Jacquet E
    Liver Int; 2016 Apr; 36(4):547-54. PubMed ID: 26502295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation.
    Maurel P; Prémaud A; Carrier P; Essig M; Barbier L; Rousseau A; Silvain C; Causse X; Debette-Gratien M; Jacques J; Marquet P; Salamé E; Loustaud-Ratti V
    Transplantation; 2021 Jul; 105(7):1585-1594. PubMed ID: 32639405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary neutrophil gelatinase-associated lipocalin and cystatin C compared to the estimated glomerular filtration rate to predict risk in patients with suspected acute myocardial infarction.
    von Jeinsen B; Kraus D; Palapies L; Tzikas S; Zeller T; Schauer A; Drechsler C; Bickel C; Baldus S; Lackner KJ; Münzel T; Blankenberg S; Zeiher AM; Keller T
    Int J Cardiol; 2017 Oct; 245():6-12. PubMed ID: 28778467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.
    Portal AJ; McPhail MJ; Bruce M; Coltart I; Slack A; Sherwood R; Heaton ND; Shawcross D; Wendon JA; Heneghan MA
    Liver Transpl; 2010 Nov; 16(11):1257-66. PubMed ID: 21031541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study).
    Ribitsch W; Schilcher G; Quehenberger F; Pilz S; Portugaller RH; Truschnig-Wilders M; Zweiker R; Brodmann M; Stiegler P; Rosenkranz AR; Pickering JW; Horina JH
    Sci Rep; 2017 Jan; 7():41300. PubMed ID: 28128223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Favorable Kidney Function in Pediatric Liver Transplant Recipients: Results of a Single-center Cohort Study.
    Sato M; Kaneko T; Ogura M; Kamei K; Ito S; Fukuda A; Sakamoto S; Kasahara M; Ishikura K
    Transplantation; 2019 Aug; 103(8):1655-1662. PubMed ID: 30489480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early predictors of renal dysfunction in cirrhotic patients after liver transplantation.
    Piñero F; Bandi J; Tisi Baña M; Casciato P; Villamil A; Galdame O; de Santibañés E; Gadano A
    Acta Gastroenterol Latinoam; 2014; 44(4):316-22. PubMed ID: 26753383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome.
    Gomaa SH; Shamseya MM; Madkour MA
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):692-702. PubMed ID: 30601335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients.
    Lin HY; Hwang DY; Lee SC; Kuo HT; Kuo MC; Chang JM; Tsai JC; Hung CC; Hwang SJ; Chen HC
    Clin Chem Lab Med; 2015 Jan; 53(1):73-83. PubMed ID: 25153411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of gender and NASH on chronic kidney disease before and after liver transplantation.
    Fussner LA; Charlton MR; Heimbach JK; Fan C; Dierkhising R; Coss E; Watt KD
    Liver Int; 2014 Sep; 34(8):1259-66. PubMed ID: 24262002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.